Embecta Corp.
USD3.31
-0.18 (-5.16%)
CEO
Devdatt Kurdikar
IPO Date
2022-03-22
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$3.46
Prev. Close
$3.49
Day Low
$3.30
Day High
$3.50
52W Low
$2.77
52W High
$15.55
Market Cap
$0.20B
Volume
1.76M
| 22,841 |
| $0.00 |
| 13 Feb 2026 | HOMBACH ROBERT J. | director | A-Award | Acquired | 22,841 | $0.00 |
| 13 Feb 2026 | Morris Milton Mayo | director | A-Award | Acquired | 22,841 | $0.00 |
| 13 Feb 2026 | Prange Karen | director | A-Award | Acquired | 22,841 | $0.00 |
| 13 Feb 2026 | Pomeroy Claire | director | A-Award | Acquired | 22,841 | $0.00 |
| 13 Feb 2026 | Reidy Christopher R | director | A-Award | Acquired | 22,841 | $0.00 |
| 3 Dec 2025 | Mann Jeffrey Z | officer | Disposed | 0 | $0.00 |
| 3 Dec 2025 | Elguicze Jacob | officer | Disposed | 0 | $0.00 |
| 1 Dec 2025 | Roth Anthony M. | Chief Accounting Officer | A-Award | Acquired | 32,817 | $0.00 |
| Tom Cole |
| Purchase |
| $1,001 - $15,000 |